Tiziana Life Sciences Ltd (TLSA) stock

TLSANasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 1, 2026Score 3/30

$0.61−0.01 (-1.61%)

Close on Nov 12, 2026Market cap $73.51MP/E –Yield –

Tiziana Life Sciences statistics

53 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Dec 31, 2025
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $73.51M; $272.32M
Enterprise Value: $69.50M; $146.23M

Share statisticsIndustry

Shares Outstanding: 121M; 58M
Shares Change (YoY): 10.9%; 10.8%
Float: 21M; 49M
Shares Held by Insiders: 82.3%; 11.7%

Short sellingIndustry

Short Interest: 3M; –
Short Interest Change: 4.71%; -0.80%
Short % of Float: 13.7%; 9.01%
Short % of Shares Outstanding: 2.43%; 6.30%
Days to Cover: 6.98; 5.15

Stock price statisticsIndustry

52-Week High: $1.90; –
52-Week Low: $0.57; –
20-Day Moving Average: $0.81; –
50-Day Moving Average: $0.93; –
200-Day Moving Average: $1.17; –
Average True Range (14): $0.08; –
Price Change (1 Week): -1.61%; -1.15%
Price Change (1 Month): -41.9%; -4.87%
Price Change (3 Months): -46.3%; -21.0%
Price Change (6 Months): -57.9%; -20.6%
Price Change (YTD): -59.1%; -23.6%
Price Change (1 Year): -64.9%; -22.4%
Price Change (3 Years): 5.17%; -29.5%
Price Change (5 Years): -56.1%; -77.9%
Average Volume (10 Days): 746,128; –
Average Volume (20 Days): 541,569; –
Average Volume (90 Days): 683,921; –
Relative Volume: 0.29; 0.70
Relative Strength Index (14): 30.5; 43.4
Volatility (1 Year): 85.3%; 80.1%
Beta (5 Years): -0.05; 1.07

Returns on capitalIndustry

Return on Capital Employed (ROCE): -7388.8%; -37.9%

Financial positionIndustry

Current Ratio: 0.76; 3.30
Quick Ratio: 0.36; 2.39
Interest Coverage: -1174.00; -6.35

EfficiencyIndustry

Employee Count: 10; 74
WACC: 7.60%; 10.2%

Income statement (TTM)Industry

Operating Income: -$21.13M; -$21.37M
Pretax Income: -$18.43M; -$12.95M
EBITDA: -$21.13M; -$17.21M
EPS (Diluted): -$0.16; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $4.01M; $68.68M
Net Cash (Debt): $4.01M; $17.76M
Net Cash Per Share: $0.03; $0.80
Working Capital: -$2.66M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$12.85M; -$12.38M
Capital Expenditures: -$21.00K; -$1.00M
Free Cash Flow: -$12.87M; -$18.21M
FCF Per Share: -$0.11; -$0.42

Dividends and yieldsIndustry

FCF Yield: -17.5%; -9.44%

Taxes and interestIndustry

Interest Expense: $18.00K; $2.90M

Scores and fair valueIndustry

Altman Z-Score: -22.36; 0.23

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	TLSA	S&P 500	Difference	TLSA per year	S&P 500 per year
1 month	-44.0%	-2.7%	−41.3 pts
3 months	-38.4%	-1.7%	−36.6 pts
Year to date	-59.1%	+11.9%	−71.0 pts
1 year	-65.7%	+12.0%	−77.7 pts
3 years	+3.4%	+78.2%	−74.8 pts	+1.1%	+21.2%
5 years	-56.1%	+73.2%	−129.4 pts	-15.2%	+11.6%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

3M TLSA shares were sold short on Oct 30, 2026, up 4.7% from the previous report, or 13.66% of the shares available to trade. At recent volumes it would take 7.0 days to buy them back. Over the last 20 sessions, 28.0% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	2,922,342	+4.7%	418,588	7.0
Oct 15, 2026	2,790,904	+5.7%	653,016	4.3
Sep 30, 2026	2,640,735	+52.3%	824,539	3.2
Sep 15, 2026	1,733,862	+2.0%	489,911	3.5
Aug 31, 2026	1,699,591	+0.0%	1,006,165	1.7
Aug 14, 2026	1,699,378	-0.2%	1,314,969	1.3
Jul 31, 2026	1,702,954	+36.7%	246,065	6.9
Jul 15, 2026	1,245,738	-20.4%	269,717	4.6
Jun 30, 2026	1,565,672	-1.4%	163,629	9.6
Jun 15, 2026	1,588,324	+8.8%	238,402	6.7
May 29, 2026	1,460,023	+3.2%	359,740	4.1
May 15, 2026	1,414,623	+3.9%	155,237	9.1

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?